Abraxane (paclitaxel protein-bound particles for injectable suspension) in combination with gemcitabine is the first new treatment approved for metastatic adenocarcinoma of the pancreas in nearly ...

The reorganisation has been prompted by the HALO-301 trial, which was testing PEGPH20 (pegvorhyaluronidase alfa) as a first-line therapy alongside gemcitabine and Celgene’s Abraxane (nab ...

Pancreatic cancer is the fourth leading cause of cancer death in the US, with over 35,000 deaths reported in 2009. 1 In 1997, gemcitabine became the standard of care for advanced disease and since ...

The company's financial results dipped following the loss of patent exclusivity of two important medicines in its arsenal: cancer drugs Revlimid (its former top-selling product) and Abraxane.

Shares of Cipla skyrocketed 10 percent on October 31 after the US Food and Drug Administration classified the drugmaker's Goa manufacturing facility as 'Voluntary Action Indicated' (VAI), thereby ...

Bristol Myers has returned to top-line growth despite generic erosion related to Revlimid and Abraxane thanks to new approvals. Since 2019, the company has launched plenty of brand-new drugs.

The Goa facility was earlier re-inspected by the regulator between June 10 – June 21, 2024, post which, six observations were issued. The VAi status now paves the way for key niche launches like the ...

Private equity, hedge funds and real estate: Which alternative investment funds will lead the way for retail investors in 2025?

Guselkumab for treating moderately to severely active ulcerative colitis ID6237 Technology appraisal guidance TBC Glofitamab with gemcitabine and oxaliplatin for treating relapsed or refractory ...

Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China ...